title: New therapeutic approaches in primary IgA nephropathy.
authors.affiliation: Department of Nephrology and Dialysis, Ospedale di Lecco, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.forename: C
authors.initials: C
authors.lastname: Pozzi
authors.forename: L
authors.initials: L
authors.lastname: Del Vecchio
authors.forename: S
authors.initials: S
authors.lastname: Andrulli
authors.forename: P
authors.initials: P
authors.lastname: Bolasco
authors.forename: G
authors.initials: G
authors.lastname: Fogazzi
authors.forename: P
authors.initials: P
authors.lastname: Altieri
authors.forename: C
authors.initials: C
authors.lastname: Ponticelli
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D004359:Drug Therapy, Combination; D005395:Fish Oils / Q000627:therapeutic use; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D009398:Nephrology / Q000639:trends*; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013256:Steroids / Q000627:therapeutic use
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005395:Fish Oils; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013256:Steroids